107.521 articles found

Effect of bilateral subthalamic electrical stimulation in Parkinson's disease.

Broggi G, Franzini A, Ferroli P, Servello D, D'Incerti L, Genitrini S, Soliveri P, Girotti F, Caraceni T.

Surg Neurol · 2001-08-01

DOI: 10.1016/s0090-3019(01)00533-xPMID: 11580941

Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease.

van de Vijver DA, Stricker BH, Breteler MM, Roos RA, Porsius AJ, de Boer A.

Pharm World Sci · 2001-08-01

DOI: 10.1023/a:1011807919632PMID: 11599201

Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.

Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Ogawa K, Mizutani T.

J Neurosurg · 2001-08-01

DOI: 10.3171/jns.2001.95.2.0213PMID: 11780890

Enhancement of the response to levodopa therapy after intrastriatal transplantation of autologous sympathetic neurons in patients with Parkinson disease.

Nakao N, Kakishita K, Uematsu Y, Yoshimasu T, Bessho T, Nakai K, Naito Y, Itakura T.

J Neurosurg · 2001-08-01

DOI: 10.3171/jns.2001.95.2.0275PMID: 11780898

Semantic priming in Parkinson's disease: evidence for delayed spreading activation.

Arnott WL, Chenery HJ, Murdoch BE, Silburn PA.

J Clin Exp Neuropsychol · 2001-08-01

DOI: 10.1076/jcen.23.4.502.1224PMID: 11780949

Discourse priming of homophones in individuals with dominant nonthalamic subcortical lesions, cortical lesions and Parkinson's disease.

Copland DA, Chenery HJ, Murdoch BE.

J Clin Exp Neuropsychol · 2001-08-01

DOI: 10.1076/jcen.23.4.538.1233PMID: 11780952

Characterization and localization of cytochrome P450 mediated metabolism of MPTP to nor-MPTP in mouse brain: relevance to Parkinson's disease.

Upadhya SC, Boyd MR, Ravindranath V.

Neurotox Res · 2001-08-01

DOI: 10.1007/bf03033198PMID: 14715467

[Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease].

Liu P, Liu Z, Shao M, Chen B.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi · 2001-08-01

PMID: 11484167

Plasma levels of vitamin E in Parkinson's disease.

Nicoletti G, Crescibene L, Scornaienchi M, Bastone L, Bagalà A, Napoli ID, Caracciolo M, Quattrone A.

Arch Gerontol Geriatr · 2001-08-01

DOI: 10.1016/s0167-4943(01)00092-9PMID: 11461717

Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism.

Aoi M, Date I, Tomita S, Ohmoto T.

Restor Neurol Neurosci · 2001-08-01

PMID: 11490075

Sensitive determination of dopamine on poly(aminobenzoic acid) modified electrode and the application toward an experimental Parkinsonian animal model.

Xu F, Gao M, Wang L, Shi G, Zhang W, Jin L, Jin J.

Talanta · 2001-08-01

DOI: 10.1016/s0039-9140(01)00432-5PMID: 18968377

Stable transdermal therapeutic system containing pramipexol or ropinirol, especially for treating Parkinson's disease, comprises backing, drug-containing pressure-sensitive adhesive matrix and protective layers

BEIER CORNELIA, WILHELM MARTINA.

· 2001-07-28